BSE: STAR - Strides Pharma Science Limited

Altı ay boyunca karlılık: -33.73%

Promosyon programı Strides Pharma Science Limited

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

daha fazla ayrıntı
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 619.05
Günlük fiyat değişimi: +0.9531% (619.05)
Haftalık fiyat değişimi: -8.51% (683.05)
Aylık fiyat değişimi: -12.81% (716.8)
3 ayda fiyat değişimi: -60.08% (1565.65)
Altı ayda fiyat değişimi: -33.73% (943.05)
Yıllık fiyat değişimi: -8.51% (683.1)
3 yılda fiyat değişimi: +39.5% (448)
5 yılda fiyat değişimi: +62.41% (384.8)
10 yılda fiyat değişimi: 0% (624.95)
Yılbaşından bu yana fiyat değişimi: -10.63% (699.3)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Toplam: 5.5

Yeterlik

İsim Anlam Seviye
ROA, % -1.13 0
ROE, % -3.26 0
Toplam: 0.6667

Temettüler

İsim Anlam Seviye
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Toplam: 1.79

Görev

İsim Anlam Seviye
Debt/EBITDA 11.07 0
Toplam: 5.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 49.63 6
karlılık Ebitda, % -46.65 0
karlılık EPS, % -289.02 0
Toplam: 3.2
Daha fazla ayrıntı

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 yıl)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 yıl)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 yıllar)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 yıllar)

Adres: India, Bengaluru, Strides House - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.strides.com